国产精品久久婷婷六月丁香的直播内容_欧美v亚洲v日韩v最新在线特_欧美日韩每日更新在线_黄片原视频无遮挡_亚洲欧美专区中文字幕_青草青草久热精品视频国产_zooskvideos性欧美另类异族_韩国精品三级bd高清中字_欧美精品综合一区_国产91综合三级久射久

CN

cooperation

Established close industry-university-research cooperation relationship with Shanghai University and Suzhou Institute of Biomedical Engineering Technology, Chinese Academy of Sciences

01
Cooperation with Shanghai University

With the help of the school's professional advantages in automatic control and software engineering,

Focus on the research and development of high-end molecular diagnostic instruments such as automatic nucleic acid extraction and purification instrument, magnetic particle chemiluminescence immunoassay instrument, etc.

More
02
Chinese Academy of Sciences
Suzhou Institute of Biomedical Engineering Technology

In cooperation with the Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, the focus is on the development of rapid nucleic acid detection instruments for the new coronavirus.

More

products

  • 臨床檢驗器械
  • 診斷試劑盒
  • 樣本采集及處理
  • 關(guān)鍵原材料
  • 分子POCT核酸快檢

    應(yīng)用場景:如用于新型冠狀病毒的核酸快速檢測。


    More
    磁微粒-吖啶酯化學(xué)發(fā)光儀

    主要用于重癥感染多標(biāo)志物聯(lián)合檢測

    More
    全自動核酸提取純化儀NEM-24

    工作原理:磁珠吸附法

    結(jié)構(gòu)組成:由機(jī)械部分和電氣部分組成

    More
    全自動化學(xué)發(fā)光免疫分析儀 Mac-S
    (磁微粒、吖啶酯、直接發(fā)光)

    定位:高效、快速、小型、低通量、多指標(biāo)

    可在病人床邊應(yīng)用的POCT產(chǎn)品。

    More

    development

    2021

    The Anhui Provincial Department of Human Resources and Social Security approved the establishment of a provincial post-doctoral research station.
    Immuno-POCT production line-automatic chemiluminescence immunoassay analyzer was approved for marketing.
    Immune POCT production line - IL6, IL10, PCT, SAA, passed the registration test.
    The immune POCT production line-influenza virus immunochromatographic rapid detection kit was successfully developed.
    Molecular POCT production line-New coronavirus nucleic acid RPA rapid detection kit was successfully developed.
    The cell capture platform-cell sorter and CTC identification reagent were successfully developed.
    Medical rehabilitation platform-electronic moxibustion therapeutic apparatus, completed multi-center clinical trials and submitted to Anhui Provincial Food and Drug Administration for registration review.
    The science and technology projects in Anhui Province and Xuancheng City have passed the acceptance.

    2020

    high-tech enterprises
    Xuancheng Molecular Diagnostics High-end Medical Device Engineering Technology Research Center
    The revenue exceeds 20 million yuan, and it is included in the "industrial enterprises above designated size"
    Xuancheng's "Top Ten" Science and Technology Innovation Enterprises
    Immune POCT production line - fully automatic chemiluminescence immunoassay analyzer, passed the registration inspection.
    Immune POCT line-infection detection markers into production transformation.
    Core raw materials: Nano magnetic beads and colored microspheres were successfully developed and put into application
    Received the Announcement City 2020 Science and Technology Project.
    6 new patents have been applied, including 3 invention patents.

    2019

    The project was approved by the high-level scientific and technological talent team of Anhui Province
    Won the key research and development project of Anhui Provincial Department of Science and Technology
    Announced city science and technology project project
    Immuno-POCT production line-automatic chemiluminescence instrument was successfully developed
    Diagnostic reagent GMP workshop was constructed and put into production
    Exosome purification reagent successfully developed
    3 new patent applications

    2018

    Fully automatic nucleic acid extraction and purification instrument was approved for listing; won the "Zhong Nanshan Science and Technology Innovation Award"
    The first prototype of the fully automatic chemiluminescence instrument was successfully developed and entered into the functional test

    2017

    2017.9.29The company was established
    Complete plant construction within 2 months

    • 2021
    • 2020
    • 2019
    • 2018
    • 2017

    news

  • 2022-02-12 安徽為臻姜劍國先生榮獲宣城“特殊人才”獎

    虎年新春,為真生物旗下子公司安徽為臻傳喜訊。在2月9日國家級宣城經(jīng)濟(jì)技術(shù)開發(fā)區(qū)召開的“雙招雙引項目建設(shè)暨工業(yè)發(fā)展大會”上,安徽

  • 2022-01-19 醫(yī)學(xué)魔改大師玩跨界,CRISPR遇見分子診斷

    2020年,瑞典皇家科學(xué)院將諾貝爾化學(xué)獎授予Jennifer Doudna教授Emmanuelle Charpentier博士以表彰她們在CRISPR/Cas9基因編輯方法上

  • 2021-09-13 為真生物與桐樹基因簽署十年戰(zhàn)略合作,共創(chuàng)伴隨診斷產(chǎn)品市場新概念

    為真生物與桐樹基因簽署十年戰(zhàn)略合作,共創(chuàng)伴隨診斷產(chǎn)品市場新概念2021年9月9日,值為真生物13周年之際,與上海桐樹基因達(dá)成3個伴隨診

  • ABOUT

    Strive for Best, Strive for Greatness

    Weizhenbio Bioengineering Technology Co., Ltd. founded in 2017, is a national-level high-tech enterprise focusing on the construction of immune and molecular POCT production lines. High-end medical device engineering technology research center.

    About us
  • 4200

    Business area

  • 2000million

    Registered capital

  • 33items

    Company patent

  • 60

    R & D personnel

  • Hotline: 0563-2827-888 / 0563-8766-2906

    Address: Building B17, Science and Technology Park, Xuancheng Economic and Technological Development Zone, Anhui Province